EP Patent

EP1799647A1 — Alkil-pyridines as 11-beta inhibitors for diabetes

Assigned to F Hoffmann La Roche AG · Expires 2007-06-27 · 19y expired

What this patent protects

Compounds of formula (I), as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.

USPTO Abstract

Compounds of formula (I), as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.

Drugs covered by this patent

Patent Metadata

Patent number
EP1799647A1
Jurisdiction
EP
Classification
—
Expires
2007-06-27
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.